Abeona Therapeutics (NASDAQ: ABEO) reported Q2 EPS of $1.71, $2.09 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $400 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.